Found: 21
Select item for more details and to access through your institution.
A Rapidly Developing Nodule in a Patient With Hairy Cell Leukemia in Remission: Merkel Cell Carcinoma: A Case Report.
- Published in:
- In Vivo, 2024, v. 38, n. 5, p. 2540, doi. 10.21873/invivo.13727
- By:
- Publication type:
- Article
Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
New Insights into Monoclonal B-Cell Lymphocytosis.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/258917
- By:
- Publication type:
- Article
Immunohistochemical Analysis of IL-6, IL-8/CXCR2 Axis, <sup>Tyr</sup>p-STAT-3, and SOCS-3 in Lymph Nodes from Patients with Chronic Lymphocytic Leukemia: Correlation between Microvascular Characteristics and Prognostic Significance.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/251479
- By:
- Publication type:
- Article
Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/159632
- By:
- Publication type:
- Article
Potential role of AKT/mTOR signalling proteins in hairy cell leukaemia: association with BRAF/ERK activation and clinical outcome.
- Published in:
- Scientific Reports, 2016, p. 21252, doi. 10.1038/srep21252
- By:
- Publication type:
- Article
Prognostic Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia.
- Published in:
- Advances in Hematology, 2013, p. 1, doi. 10.1155/2013/359071
- By:
- Publication type:
- Article
Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.
- Published in:
- British Journal of Haematology, 2007, v. 137, n. 3, p. 240, doi. 10.1111/j.1365-2141.2007.06561.x
- By:
- Publication type:
- Article
Identification of Very Low‐Risk Subgroups of Patients with Primary Mediastinal Large B‐Cell Lymphoma Treated with R‐CHOP.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. 597, doi. 10.1002/onco.13789
- By:
- Publication type:
- Article
Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens.
- Published in:
- Oncologist, 2016, v. 21, n. 3, p. 343, doi. 10.1634/theoncologist.2015-0251
- By:
- Publication type:
- Article
Treatment of Splenic Marginal Zone Lymphoma With Rituximab Monotherapy: Progress Report and Comparison With Splenectomy.
- Published in:
- Oncologist, 2013, v. 18, n. 2, p. 190, doi. 10.1634/theoncologist.2012-0251
- By:
- Publication type:
- Article
Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone with or Without Radiotherapy in Primary Mediastinal Large B-Cell Lymphoma: The Emerging Standard of Care.
- Published in:
- Oncologist, 2012, v. 17, n. 2, p. 239, doi. 10.1634/theoncologist.2011-0275
- By:
- Publication type:
- Article
Early-Stage Gastric MALT Lymphoma: Is It a Truly Localized Disease?
- Published in:
- Oncologist, 2009, v. 14, n. 2, p. 148, doi. 10.1634/theoncologist.2008-0178
- By:
- Publication type:
- Article
Clinical Aspects of Malt Lymphomas.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 3, p. 262, doi. 10.1007/s11899-014-0218-1
- By:
- Publication type:
- Article
Validation of the simplified International Prognostic Score3 in a Hellenic cohort of patients with advanced‐stage Hodgkin‐lymphoma.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 6, p. e335, doi. 10.1111/bjh.16903
- By:
- Publication type:
- Article
Prognostic Impact of Serum β 2 -Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients.
- Published in:
- Cancers, 2024, v. 16, n. 2, p. 238, doi. 10.3390/cancers16020238
- By:
- Publication type:
- Article
Real‐life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B‐cell lymphomas.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 336, doi. 10.1002/hon.2842
- By:
- Publication type:
- Article
Detection of L265P MYD-88 mutation in a series of clonal B-cell lymphocytosis of marginal zone origin (CBL-MZ).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Real-life Experience With Rituximab-CHOP Every 21 or 14 Days in Primary Mediastinal Large B-cell Lymphoma.
- Published in:
- In Vivo, 2022, v. 36, n. 3, p. 1302, doi. 10.21873/invivo.12831
- By:
- Publication type:
- Article
Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 9, p. 2279, doi. 10.1007/s00277-021-04421-2
- By:
- Publication type:
- Article
Alveolar bone histological necrosis observed prior to extractions in patients, who received bone‐targeting agents.
- Published in:
- Oral Diseases, 2020, v. 26, n. 5, p. 955, doi. 10.1111/odi.13294
- By:
- Publication type:
- Article